M. Dreyling

2.5k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

M. Dreyling is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, M. Dreyling has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 10 papers in Genetics. Recurrent topics in M. Dreyling's work include Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (14 papers) and Chronic Lymphocytic Leukemia Research (10 papers). M. Dreyling is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (14 papers) and Chronic Lymphocytic Leukemia Research (10 papers). M. Dreyling collaborates with scholars based in Germany, Italy and France. M. Dreyling's co-authors include Marco Ladetto, Simon Rule, Ofer Shpilberg, Jan Walewski, Olivier Hermine, Umberto Vitolo, Michele Ghielmini, Gilles Salles, Mats Jerkeman and Steven Le Gouill and has published in prestigious journals such as Annals of Oncology, British Journal of Haematology and Leukemia.

In The Last Decade

M. Dreyling

20 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2017 412 citations M. Dreyling, Elı́as Campo et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Dreyling Germany	16	1.2k	773	438	261	182	22	1.3k
Roswitha Forstpointner Germany	15	1.5k 1.3×	1.1k 1.5×	732 1.7×	188 0.7×	235 1.3×	38	1.7k
P. Solal-Céligny France	8	1.2k 1.0×	818 1.1×	539 1.2×	389 1.5×	131 0.7×	14	1.5k
David Belada Czechia	18	819 0.7×	604 0.8×	327 0.7×	175 0.7×	124 0.7×	167	1.1k
Dorothea Kofahl-Krause Germany	10	1.5k 1.3×	984 1.3×	921 2.1×	256 1.0×	156 0.9×	15	1.6k
J. Matthews United Kingdom	13	988 0.9×	664 0.9×	428 1.0×	158 0.6×	126 0.7×	20	1.1k
Christina Balser Germany	11	1.3k 1.1×	903 1.2×	825 1.9×	219 0.8×	128 0.7×	18	1.6k
Liliana Devizzi Italy	22	1.5k 1.3×	960 1.2×	478 1.1×	456 1.7×	376 2.1×	59	1.9k
Ulrich von Grünhagen Germany	6	1.2k 1.1×	849 1.1×	789 1.8×	197 0.8×	129 0.7×	10	1.4k
Charles Foussard France	12	885 0.8×	601 0.8×	356 0.8×	195 0.7×	59 0.3×	22	1.0k
Christopher Pocock United Kingdom	23	1.2k 1.1×	809 1.0×	1.1k 2.6×	349 1.3×	125 0.7×	64	2.1k

Countries citing papers authored by M. Dreyling

Since Specialization

Citations

This map shows the geographic impact of M. Dreyling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dreyling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dreyling more than expected).

Fields of papers citing papers by M. Dreyling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dreyling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dreyling. The network helps show where M. Dreyling may publish in the future.

Co-authorship network of co-authors of M. Dreyling

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dreyling. A scholar is included among the top collaborators of M. Dreyling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dreyling. M. Dreyling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

d’Amore, Francesco, Massimo Federico, Laurence de Leval, et al.. (2025). Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 36(6). 626–644.

Dreyling, M., Michele Ghielmini, Simon Rule, et al.. (2020). Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 32(3). 298–308. 132 indexed citations

Dreyling, M., Elı́as Campo, Olivier Hermine, et al.. (2017). Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 28(3). iv62–iv71. 412 indexed citations breakdown →

Dreyling, M., Michele Ghielmini, Simon Rule, et al.. (2016). Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 27(suppl 5). v83–v90. 137 indexed citations

Dreyling, M., et al.. (2016). The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?. Haematologica. 101(2). 104–114. 25 indexed citations

Keller, Ulrich, Christian W. Scholz, Mathias Witzens‐Harig, et al.. (2015). Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma. Leukemia. 29(8). 1695–1701. 30 indexed citations

Dreyling, M., Carsten Geisler, Olivier Hermine, et al.. (2014). Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 25. iii83–iii92. 91 indexed citations

Dreyling, M., Michele Ghielmini, Robert Marcus, et al.. (2014). Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 25. iii76–iii82. 54 indexed citations

Robinson, Stephen, Peter Dreger, Dolores Caballero, et al.. (2014). The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma. Leukemia. 29(2). 464–473. 38 indexed citations

10.

Dreyling, M., Simone Ferrero, & Olivier Hermine. (2014). How to manage mantle cell lymphoma. Leukemia. 28(11). 2117–2130. 29 indexed citations

11.

Tilly, Hervé, Umberto Vitolo, Jan Walewski, et al.. (2012). Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23. vii78–vii82. 122 indexed citations

12.

Witzens‐Harig, Mathias, J. Atta, Georg Lenz, et al.. (2012). Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting. Annals of Hematology. 91(11). 1765–1772. 8 indexed citations

13.

Dreyling, M., et al.. (2011). Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 22. vi59–vi63. 92 indexed citations

14.

Engert, Andreas, Dennis A. Eichenauer, & M. Dreyling. (2010). Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21. v168–v171. 42 indexed citations

15.

Dreyling, M.. (2010). Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21. v181–v183. 22 indexed citations

16.

Dummer, Reinhard & M. Dreyling. (2008). Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology. 19. ii72–ii76. 43 indexed citations

17.

Gleissner, Beate, Ralf Küppers, Reiner Siebert, et al.. (2008). Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling. British Journal of Haematology. 142(2). 166–178. 8 indexed citations

18.

Dreyling, M., Oliver Weigert, & Wolfgang Hiddemann. (2008). Current treatment standards and future strategies in mantle cell lymphoma. Annals of Oncology. 19. iv41–iv44. 17 indexed citations

19.

Dreyling, M., et al.. (2006). Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy. Annals of Hematology. 86(2). 81–87. 27 indexed citations

20.

Hiddemann, Wolfgang, M. Dreyling, & Rolf A. Stahel. (2005). Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma. Annals of Oncology. 16. i56–i57. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact